Healthcare & Biotech

Vancouver – September 04, 2026 -- Hydreight Technologies Inc. (TSXV: NURS) (OTCQB: HYDTF) reported second-quarter 2026 revenue of $28.0 million, a 421% increase from $5.4 million a year earlier, as its VSDHOne virtual healthcare platform drove the company's strongest quarter on record.

Net income jumps to $2.5 million as pharmacy sales scale

Gross profit rose 182% to $5.4 million, while net income reached $2.5 million versus just $0.05 million in Q2 2025. Adjusted EBITDA climbed to $3.2 million from $0.2 million a year prior. Revenue grew approximately 12.5% and gross profit approximately 7% quarter-over-quarter versus Q1 2026, with net income and Adjusted EBITDA holding steady sequentially.

Minneapolis – September 04, 2026 -- The American Academy of Neurology (AAN) and American Headache Society (AHS) have issued a joint update to their 2012 clinical practice guideline on migraine prevention medications for adults, published simultaneously in Neurology and Headache journals on August 31, 2026.

Guideline sets clear treatment threshold for clinicians

The update recommends preventive treatment for patients experiencing four or more migraine days per month, four or more moderate-to-severe headache days per month, or migraine that impairs their ability to work or complete daily tasks. It distinguishes between chronic migraine, defined as 15 or more headache days a month with at least eight showing migraine features, and episodic migraine, which occurs on fewer days per month.

Fort Lauderdale, Florida – September 04, 2026 -- IGEL has added Teguar to its IGEL Ready ecosystem, certifying the manufacturer's rugged and specialized hardware for use with IGEL OS in healthcare, manufacturing and warehouse settings.

Teguar brings purpose-built systems for environments unsuited to commercial-grade devices

Teguar's portfolio includes rugged, waterproof industrial computers alongside all-in-one systems and tablets designed for clinical use. The hardware targets operational conditions where standard commercial endpoints fail to meet durability or workflow requirements.

New Haven, Conn. – September 04, 2026 -- Wellinks, a virtual-first cardiopulmonary care company, has appointed Andrew Agwunobi, MD, MBA, and Mike Waters to its Board of Directors while adding three vice presidents to its management team, the company said.

Former Teladoc COO Mike Waters joins Wellinks board with digital health portfolio

Waters, who spent more than two decades in strategic operations and previously served as Chief Operating Officer of Teladoc Health, also brings 15-plus years from Providence Health, where he was Executive Vice President and Chief Executive of its Ambulatory Care Network. He currently holds board roles across six digital health companies, including Chair positions at Ieso and Brook Health.

Las Vegas – September 03, 2026 -- Paralyzed Veterans of America (PVA) opened its 2026 Healthcare Summit + Expo at the Horseshoe Hotel, drawing more than 400 healthcare professionals to advance clinical care for spinal cord injury, MS, and ALS. The event runs through September 2 and features 110 speakers and 60 exhibitors, with remarks from Department of Veterans Affairs Secretary Doug Collins.

Summit connects 400 clinicians to close gaps in SCI/D care

PVA National President Robert Thomas said healthcare for veterans with traumatic spinal cord injuries and diseases like MS and ALS extends from research through rehabilitation and long-term community life. PVA, founded in 1946, is the only nonprofit Veterans Service Organization with access inside all 25 VA SCI/D Centers, a position that has shaped its 80-year investment in research, clinical education, and advocacy.

Chicago – September 03, 2026 -- The American Board of Medical Specialties (ABMS) Research and Education Foundation (REF) has awarded $300,000 in research grants to four independent investigators for its 2026-2028 cycle, the third year of the program.

ABMS Foundation issues four $75,000 grants over two-year terms

Each recipient will receive $75,000 spread across a two-year project period, running from August 31, 2026 through August 31, 2028. The awards fund independent research into the structures, processes, and outcomes tied to physician board certification, with particular focus on continuing certification's role in patient care.

South Jordan, Utah -- September 01, 2026 -- Opalescence Whitening launched Opalescence Go Advanced, a prefilled take-home whitening tray built on a redesigned UltraFit tray that eliminates the outer placement tray used in prior generations. The company, which markets itself as the top-selling professional teeth whitening brand worldwide, said the new product ships ready to use directly from the package. Opalescence has whitened more than 150 million smiles globally since its formula first reached the dental market 35 years ago.

BEIJING -- September 01, 2026 -- So-Young International Inc. (Nasdaq: SY) reported total revenue of RMB505.2 million ($74.5 million) for the second quarter ended June 30, 2026, up 33.4% from RMB378.7 million a year earlier. The Beijing-based aesthetic treatment platform said revenue from its branded aesthetic centers jumped 129.5% to RMB331.4 million, exceeding the high end of its own guidance. Net loss attributable to the company narrowed to RMB22.7 million from RMB36.0 million in the second quarter of 2025.

Melbourne, Australia -- September 01, 2026 -- SIBIONICS presented its GS3 continuous glucose monitor at the joint IDF-WPR, ADC and Metabolic Diseases 2026 congress, held in Melbourne from August 18 to 21, 2026. The company used Booth #1, a scientific symposium and on-site interviews with credentialled diabetes educators to demonstrate the sensor's AI-linked meal-logging and glucose-trend features. GS3 is a factory-calibrated, 14-day continuous glucose monitor with a 2.9 mm on-body profile.

SHERIDAN, WYOMING -- July 22, 2026 -- Royal Philips has received FDA 510(k) clearance for its next-generation reusable SpO₂ clip sensor, a pulse oximetry device built around internal optical refinements that improve signal quality. In desaturation testing, the sensor posted an accuracy result nearly twice as tight as the level recommended by ISO and recognized by the FDA. It also held accuracy within half a percentage point between light and dark skin pigmentation groups tested. The clearance extends Philips' broader pulse oximetry portfolio and follows a validation program built specifically around performance across diverse patient populations.